Capricor Therapeutics Inc. (NASDAQ: CAPR)
$9.9800
-0.3600 ( -3.48% ) 5.8M
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
Market Data
Open
$9.9800
Previous close
$10.3400
Volume
5.8M
Market cap
$356.20M
Day range
$9.7220 - $11.0150
52 week range
$2.6800 - $12.8700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Aug 09, 2024 |
10-q | Quarterly Reports | 58 | Aug 08, 2024 |
8-k | 8K-related | 15 | Aug 07, 2024 |
8-k | 8K-related | 14 | May 15, 2024 |
8-k | 8K-related | 13 | May 15, 2024 |
10-q | Quarterly Reports | 57 | May 14, 2024 |
8-k | 8K-related | 15 | May 13, 2024 |
8-k | 8K-related | 42 | Apr 29, 2024 |
4 | Insider transactions | 1 | Apr 25, 2024 |
4 | Insider transactions | 1 | Apr 24, 2024 |